- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03103633
The Effects of Individualized Oxygen Dynamic on Prognosis of Patients With High-risk Cardiac Surgery
March 21, 2019 updated by: The First Affiliated Hospital of Anhui Medical University
Effects of Perioperative Goal-Directed Therapy Based on Individualized Oxygen Balance on Outcomes During High-risk Cardiac Surgery:A Single Center, Prospective,Randomized,Controlled,Double Blinded Study.
Anesthesia-related factors have been linked to poor perioperative outcomes.
Our observational study suggested that the cumulative duration of a triple-low state [intraoperative low mean arterial pressure (MAP), low bispectral index (BIS), and low target effect-site concentration(Ce) ]was associated with poorer 30-day mortality.This randomized, prospective study based on individualized Oxygen dynamics is designed to confirm this association in high-risk patients cardiopulmonary bypass (CPB).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
286
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Anhui
-
Hefei, Anhui, China, 230022
- The First Affiliated Hospital of Anhui Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Written informed consent;
- Selective cardiac surgery and general anesthesia patients;
- Age 18-90 yrs;
- Anesthesia Society of American (ASA) Scale II-IV
- European System for Cardiac Operative Risk Evaluation score equal to or greater than 6 or left ventricular ejection fraction lower than 50%
Exclusion Criteria:
- Preoperative cardiac ejection fraction<30 %;
- History of anesthesia awareness;
- History or anticipation of difficult intubation;
- Unanticipated intraoperative conditions, including haemorrhage, obstinate resuscitation failure,multiple cardiopulmonary bypass procedures, severe hypotension or hypoxemia;
- long-term preoperative use of anticonvulsant agents, opiates, benzodiazepines or cocaine.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Individualized Goal-Directed Therapy
The goal of intervention:mean artery pressure declined with less than 20% of baseline, BIS 45-60 before and after CPB; and BIS 40-45 during CPB, Brain oxygen saturation declined with less than 20% of baseline.
|
mean artery pressure declined with less than 20% of baseline
BIS 45-60 before and after CPB; and BIS 40-45 during CPB
Other Names:
Brain oxygen saturation declined with less than 20% of baseline
|
SHAM_COMPARATOR: Controlled
no intervention beside the same monitoring with MAP, BIS and brain oxygen saturation and receiving standard measures to achieve a heart rate (HR) in the range of 60-100 beats/min, central venous oxygen saturation (Svco2) higher than 70%, lactate level lower than 3 mmol/L, hematocrit value higher than 28%, and urinary output higher than 0.5 mL/kg/hr.
|
receiving standard measures to achieve a heart rate (HR) in the range of 60-100 beats/min, central venous oxygen saturation (Svco2) higher than 70%, lactate level lower than 3 mmol/L, hematocrit value higher than 28%, and urinary output higher than 0.5 mL/kg/hr.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Major postoperative complications(i.e., Rate of low cardiac output syndrome, stroke, myocardial ischemia, infection,reoperation, and need for dialysis)
Time Frame: 30-day after surgery
|
Number of Participants with major complications extracted after 30-day follow-up
|
30-day after surgery
|
30-day mortality
Time Frame: 30-day after surgery
|
Data for duration of postoperative 30-day all-cause mortality
|
30-day after surgery
|
The change of incidence of postoperative delirium
Time Frame: The 1,2,3 day after surgery
|
Through Confusion Assessment Method (CAM)to assess the incidence of the postoperative delirium
|
The 1,2,3 day after surgery
|
1,3,5-year mortality
Time Frame: 1,3,5-year after surgery
|
Data for duration of 1,3,5-year all-cause mortality is extracted after 1-year follow-up
|
1,3,5-year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative hospital stay
Time Frame: 30-day after surgery
|
Data for duration of postoperative hospital stay is extracted after 30-day follow-up
|
30-day after surgery
|
The change of incidence of postoperative cognition dysfunction
Time Frame: 1 day before surgery, the 3,7 day after the surgery
|
The neuropsychological tests performed at the day before the surgery,the 3,7 day after the surgery respectively.
|
1 day before surgery, the 3,7 day after the surgery
|
The occurrence of cardiovascular events
Time Frame: 30-day after surgery
|
Data for duration of the occurrence of cardiovascular events is extracted 30-day follow-up
|
30-day after surgery
|
The incidence of any adverse events
Time Frame: 30-day after surgery
|
Including kidney or brain related adverse events 30-day after surgery
|
30-day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 5, 2017
Primary Completion (ACTUAL)
June 30, 2018
Study Completion (ACTUAL)
July 30, 2018
Study Registration Dates
First Submitted
April 1, 2017
First Submitted That Met QC Criteria
April 5, 2017
First Posted (ACTUAL)
April 6, 2017
Study Record Updates
Last Update Posted (ACTUAL)
March 25, 2019
Last Update Submitted That Met QC Criteria
March 21, 2019
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FirstAnhuiM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Disease
-
University of British ColumbiaRecruitingSurgery | Cardiac Event | Cardiac Disease | Cardiac Complication | Cardiac Valve Disease | Surgery-ComplicationsCanada
-
Istituto Auxologico ItalianoRecruitingCardiovascular Diseases | Cardiomyopathies | Ischemic Heart Disease | Sudden Cardiac Death Due to Cardiac ArrhythmiaItaly
-
Ostfold University CollegeNot yet recruitingCardiac Arrest | Cardiac Arrhythmia | Cardiac Disease | Cardiac Death
-
Johns Hopkins UniversityNational Human Genome Research Institute (NHGRI)Enrolling by invitationGenetic Counseling | Inherited Cardiac DiseaseUnited States
-
Centro Medico TeknonRecruitingMyocardial Infarction | Ischemic Heart Disease | Ventricular Tachycardia | Magnetic Resonance Imaging | Ventricular Arrythmia | Sudden Cardiac Death | Sudden Cardiac Death Due to Cardiac ArrhythmiaSpain
-
Children's Healthcare of AtlantaTerminated
-
Beijing Chao Yang HospitalBeijing Boren Hospital; Beijing Chuiyangliu HospitalNot yet recruitingM-protein Related Cardiac Disease
-
Maastricht University Medical CenterActive, not recruitingHeart Diseases | Cardiac Conduction DefectNetherlands
-
Vanderbilt University Medical CenterCompletedCardiac DiseasesUnited States
-
St. Luke's-Roosevelt Hospital CenterCompleted
Clinical Trials on mean artery pressure
-
Cooperativa de Ensino Superior, Politécnico e UniversitárioCompleted
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
University Hospital, AngersRecruiting
-
University Hospital, AngersNot yet recruiting
-
Catharina Ziekenhuis EindhovenCompletedShock, Cardiogenic | Hypovolemia | Cardiac Failure | Shock HypovolemicNetherlands
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Bypass Graft Surgery PatientsUnited States
-
Uppsala UniversityRoche Pharma AG; Perkin Elmer Inc.; Thermo Fisher Scientific, IncActive, not recruiting
-
Niels Damkjær OlesenRecruitingOut-Of-Hospital Cardiac Arrest | Post-Cardiac Arrest SyndromeDenmark
-
University of Southern DenmarkRecruitingIntensive Care Unit | Out-Of-Hospital Cardiac Arrest | Mechanical Ventilation | Resuscitation | Oxygen Therapy | Hypertension, Pulmonary ArterialDenmark
-
Jesper KjaergaardOdense University HospitalCompletedBlood Pressure | Out-of-Hospital Cardiac Arrest | Hemodynamic InstabilityDenmark